<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药笔记 | wechat-feeds</title><link>http://MzI4MzQyMjM0Ng.favicon.privacyhide.com/favicon.ico</link><description>乘之愈往，识之愈真。如将不尽，与古为新。</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 23 Feb 2021 12:09:50 +0800</pubDate><image><url>http://MzI4MzQyMjM0Ng.favicon.privacyhide.com/favicon.ico</url><title>医药笔记 | wechat-feeds</title><link>http://MzI4MzQyMjM0Ng.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>君实生物申报EGFR-exon20小分子抑制剂</title><link>https://mp.weixin.qq.com/s/pVWzeLDrSn4pgSc3Uhc7mA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNA8QFMicJeWrVMFoDziaMQz7AoxvsDX9ZQwPDaJnwEnRB4cImFQe4qjchp1nDHRq3WXcGnmab8UsgQw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>EGFR外显子20]]></content:encoded><pubDate>Mon, 22 Feb 2021 16:14:15 +0800</pubDate></item><item><title>100款已上市抗体药物氨基酸序列</title><link>https://mp.weixin.qq.com/s/zxl0uNYyOF_qKiG_G3TleA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBcPGNwmlxOACOSyY4wWicZG7cBhib8dWEA4zySLd6bl5vLHXBbGUYtaT3ExLP0cH2hE3gABkf3NHZA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>氨基酸序列与Fc改造]]></content:encoded><pubDate>Sun, 21 Feb 2021 21:28:19 +0800</pubDate></item><item><title>100款已上市抗体药物的免疫原性</title><link>https://mp.weixin.qq.com/s/fiSEr-INBnvToOsk_Tkw0w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBcPGNwmlxOACOSyY4wWicZG30dZxIANfR09QvsygTKrS7JlUPIwYtlfVVvGfgTZ00yC6icrh8XyIiaw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>免疫原性]]></content:encoded><pubDate>Sun, 21 Feb 2021 21:28:19 +0800</pubDate></item><item><title>100款已上市抗体药物的制剂处方</title><link>https://mp.weixin.qq.com/s/SWb_HKP61b6RZEUQ5V9p_Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBcPGNwmlxOACOSyY4wWicZGMJm5V69NfnRk6lBTtKE4mbpx3EhjUHND84WZGH7DOiaU8FrjWEPuEdA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>抗体制剂]]></content:encoded><pubDate>Sun, 21 Feb 2021 21:28:19 +0800</pubDate></item><item><title>VEGF治疗眼病：罗氏的三重护城河</title><link>https://mp.weixin.qq.com/s/zMR7UzBySTYBfCjeE4VVAQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNCFXTlczQCaskjvqLGibsRTEEuRsXkqzpRbMDGIJpvvpicFIat9W1vZMKd0pibRMokFfL7HiaaqlLVFHg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>PDS、Faricimab、DutaFab]]></content:encoded><pubDate>Sat, 20 Feb 2021 14:16:17 +0800</pubDate></item><item><title>多特异性纳米抗体：或成对抗新冠变异的有效武器</title><link>https://mp.weixin.qq.com/s/Osl0PQ2_cGfYcMg1XOJxAw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDB3VddVP1SDcicAbAFib0icBcB95sutrj87VnKHEgO5ZJofLKUyyuBnjY8D1dNzWKAk624EicnhLy3ibA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>纳米双抗狙击新冠]]></content:encoded><pubDate>Fri, 19 Feb 2021 09:27:29 +0800</pubDate></item><item><title>成立6个月，联拓生物启动FGFR抑制剂三期临床</title><link>https://mp.weixin.qq.com/s/Q2ne2z7Bi8gdtWjs7v74Sg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDB3VddVP1SDcicAbAFib0icBccP7w31xoDCBWrQA0tqK025J6gKwMOA2sOS2opYN3EyMsribn0APwk9Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>FGFR]]></content:encoded><pubDate>Fri, 19 Feb 2021 09:27:29 +0800</pubDate></item><item><title>国内首个：迈威生物申报ST2抗体</title><link>https://mp.weixin.qq.com/s/fddboQe5XXcv0p4qwCDRqw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBsxX389pNL7NRWFFkSzpZuSEqgpoMuTKcK5AOLTYpe90icYIS7DB5Ac2CiaQ6c2ImT2Ww1mjkmRJIA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>IL-33/ST2]]></content:encoded><pubDate>Fri, 19 Feb 2021 09:27:29 +0800</pubDate></item><item><title>David Baker成功实现跨膜TMB的从头设计</title><link>https://mp.weixin.qq.com/s/i3saMA1qCCfPA2u-SswR9A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNBsxX389pNL7NRWFFkSzpZuyDTTSL8VJgedbE5YOPAhEUcgyHm9R3p0qHGMiawdI2aONKd0axp4gCw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>蛋白从头设计]]></content:encoded><pubDate>Fri, 19 Feb 2021 09:27:29 +0800</pubDate></item><item><title>全人源抗体</title><link>https://mp.weixin.qq.com/s/DXGT00Exm8PNDsfg39pcrg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDB3VddVP1SDcicAbAFib0icBcTibmic8ZBd30Gq7icel0fnVD79kggnZ3whxLzgOafoyje0DoI4eL83xXw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>710亿美元]]></content:encoded><pubDate>Thu, 18 Feb 2021 09:08:33 +0800</pubDate></item><item><title>豪森药业1.32亿美元引进抗真菌感染药物</title><link>https://mp.weixin.qq.com/s/NHZQyII9835qPZY6HoDQNA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDB3VddVP1SDcicAbAFib0icBcv6RHw8FM4OicBLiaxUicgpFynoKwXRAdibMbcoNALEaGibiaAlotXhibXbicAA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>预付款1000万美元]]></content:encoded><pubDate>Thu, 18 Feb 2021 09:08:33 +0800</pubDate></item><item><title>百济神州1.21亿美元引进TNFR2抗体</title><link>https://mp.weixin.qq.com/s/qSPj13mwcXnuO6qIiAcmLw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Hiacwl04JVNDB3VddVP1SDcicAbAFib0icBciaYyBMCGxf1HAQI9N3spMAl5ZZeQ3X2BXAahcUSr9JZrW9VtDEPORxw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>TNFR2]]></content:encoded><pubDate>Thu, 18 Feb 2021 09:08:33 +0800</pubDate></item></channel></rss>